Better Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Better Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2021 to Q3 2023.
  • Better Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2023 was $518K, a 27.6% increase year-over-year.
  • Better Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2023 was $1.95M.
  • Better Therapeutics, Inc. annual Interest Expense for 2022 was $1.49M, a 706% increase from 2021.
  • Better Therapeutics, Inc. annual Interest Expense for 2021 was $185K, a 85% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $1.95M $518K +$112K +27.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.84M $563K +$234K +71.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.61M $431K +$114K +36% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.49M $439K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $406K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $329K +$328K +32800% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $317K +$315K +15750% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q2 2021 $1K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.